• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

T5O:GR

62.144 EUR 7.144 12.99%

As of 15:35:03 ET on 12/22/2014.

Snapshot for CytoTools AG (T5O)

Open: 55.400 Day's Range: 53.488 - 63.500 Volume: 7,113
Previous Close: 55.000 52wk Range: 27.980 - 76.343 1-Yr Rtn: +117.74%

Stock Chart for T5O

No chart data available.
  • T5O:GR 63.500
  • 1D
  • 1M
  • 1Y
55.000
Interactive T5O Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for T5O

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -0.4295
Est. EPS (EUR) (12/2014) -0.8500
Est. PEG Ratio -
Market Cap (M EUR) 118.07
Shares Outstanding (M) 1.90
30 Day Average Volume 6,820
Price/Book (mrq) 14.4948
Price/Sale (ttm) 295.0614
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/19/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for T5O

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for T5O

Cytotools AG is a biotechnology company that discovers and develops small molecules and biologics for the treatment of chronic wounds, vascular diseases and cancer.

Mark-Andre FreybergChairman-Mgmt BoardDirk KaiserMember-Mgmt Board
Markus Hugo WeissbachChief Medical Officer
More Company Profile & Key Executives for T5O

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil